The trusted source for
healthcare information and
This is a pivotal time in the world of cannabis policy and research for healthcare. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives. This program will cover epidemiology and pharmacology of cannabinoid and review evidence-based research and methods on the health effects of cannabis and cannabinoid.
Our speaker will discuss the neurobiology and therapeutic effects of cannabinoid, including on vomiting, pain and multiple sclerosis. The speaker will evaluate the effect of cannabinoid on diseases, pregnancies, and mental health, and review cannabinoid withdrawals and treatments. Attend the webinar and develop a reliable understanding about short and long-term health outcomes of cannabis use based on scientific literature.
Anyone involved with or interested in compliance regulations and standards, including but not limited to: CEOs, CFOs, COOs, CMOs, CNOs, Physicians, Nurses (all levels), Behavioral Health Staff, Psychiatry Staff, Social Workers, and Addiction Professionals.